Intra-arterial infusion of nitric oxide (NO) - First animal trial

Boris Yoffe, Brian Levy, Dora Ben-Alon, Ohad Baruchin, Abraham Baruchin

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Objective: Nitric oxide (NO) is an important signaling molecule that acts in many tissues to regulate a diverse range of physiological processes. NO has been implicated in a number of cardiovascular diseases. Reduced basal NO synthesis or function may lead to: vasoconstriction, elevated blood pressure and thrombus formation. By contrast, overproduction of NO results in vasodilatation, hypotension, vascular leakage, and disruption of cell metabolism. The purpose of this study was to determine the effects of NO gas directly infused into the arteries. Methods: The study was performed on 28 rabbits and 10 pigs. We developed a device that enables quantitatively controlled infusion of NO gas, directly into the arteries. Results: We found that administration of NO gas via arteries caused widening of the blood vessels as well as increasing blood flow in the extremity. It emerges that. These effects persist up to 2-3 h after the NO infusion ceased. Although the NO breaks down when diffused in blood, its influence commences rapidly and continues for a relatively long time. Conclusions: Our findings indicate that, administration of NO into blood vessels causes a long lasting vasodilatation and enhanced blood flow. Despite the fact that NO is broken down rapidly.

Original languageEnglish
Pages (from-to)57-62
Number of pages6
JournalVascular Pharmacology
Volume47
Issue number1
DOIs
StatePublished - 1 Jul 2007

Keywords

  • Animal trial
  • Intraarterial delivery of NO gas
  • Nitric oxide

ASJC Scopus subject areas

  • Physiology
  • Molecular Medicine
  • Pharmacology

Fingerprint

Dive into the research topics of 'Intra-arterial infusion of nitric oxide (NO) - First animal trial'. Together they form a unique fingerprint.

Cite this